Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

FDA begins speedy review of Celgene’s Revlimid combo in lymphoma

FDA begins speedy review of Celgene’s Revlimid combo in lymphoma It also met the secondary endpoint of overall survival, with only 16 death events reported in the Revlimid combo group versus 26 death events in the comparator arm. ... It's one of five new drugs that Celgene aims to launch through 2020, and the company

Sanofi's Darzalex rival scores in myeloma trial

Sanofi's Darzalex rival scores in myeloma trial Celgene’s Revlimid (lenalidomide) and dexamethasone.

BMS isn’t phased by Opdivo’s slowing growth – for now

BMS isn’t phased by Opdivo’s slowing growth – for now over Celgene’s top-seller Revlimid (lenalidomide), which accounts for almost two-thirds of its sales but is facing the threat of generic competition in the coming years.

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

BMS and Celgene deal sparks debate on pharma profit motive, more M&A However there were also those pointing to what many see as Celgene’s abuse of patents and US regulations to protect Revlimid, its top-selling myeloma treatment, which earned over $8bn ... These rows have generated uncertainty about when Revlimid will

BMS and Celgene announce $74bn merger

BMS and Celgene announce $74bn merger setbacks in 2018 as it sought to grow beyond its myeloma blockbuster Revlimid.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics